Overview

Safety, Tolerance and Pharmacokinetics Study of Compound Edaravone Injection

Status:
Completed
Trial end date:
2019-08-16
Target enrollment:
Participant gender:
Summary
Study on the Safety, Tolerance and Pharmacokinetics of Single-dose, Increasing and Loading Dose and Maintenance Dose Sequential Intravenous Infusion of Compound Edaravone Injection in Chinese Healthy Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Nanjing Yoko Biomedical Co., Ltd.
Treatments:
Edaravone